The Patent Finder

Terms ending in 2036

Prime Merger Sub, LLC

Every in-force patent on Prime Merger Sub, LLC's record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 12,433,918Methods of Treating Joint Disease, Disorders, and Conditions with Tissue Inhibitors of Matrix Metalloproteinase
In force
 · High confidence
Prime Merger Sub, LLCIn forceHigh confidence
US 10,576,107Methods of Treating Joint Diseases, Disorders, and Conditions with Tissue Inhibitors of Matrix Metalloproteinases
In force
 · High confidence
Prime Merger Sub, LLCIn forceHigh confidence
US 11,666,606Methods of Treating Joint Disease, Disorders and Conditions with Tissue Inhibitors of Matrix Metalloproteinases
In force
 · Low confidence
Prime Merger Sub, LLCIn forceLow confidence
US 10,765,705Visco-Supplement Compositions, and Methods of Use Thereof
In force
 · High confidence
Prime Merger Sub, LLCIn forceHigh confidence
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited